Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 16, 2023

SELL
$0.39 - $0.71 $19,199 - $34,952
-49,229 Reduced 72.78%
18,410 $7,000
Q4 2022

Feb 14, 2023

SELL
$0.33 - $10.44 $3,416 - $108,095
-10,354 Reduced 13.28%
67,639 $27,000
Q3 2022

Nov 14, 2022

SELL
$0.92 - $11.16 $46,292 - $561,548
-50,318 Reduced 39.22%
77,993 $66,000
Q2 2022

Aug 15, 2022

BUY
$1.02 - $1.83 $12,467 - $22,368
12,223 Added 10.53%
128,311 $149,000
Q1 2022

May 16, 2022

SELL
$1.06 - $2.1 $260,175 - $515,442
-245,449 Reduced 67.89%
116,088 $164,000
Q4 2021

Feb 14, 2022

SELL
$2.05 - $3.2 $44,042 - $68,748
-21,484 Reduced 5.61%
361,537 $741,000
Q3 2021

Nov 15, 2021

BUY
$2.54 - $4.07 $148,437 - $237,850
58,440 Added 18.0%
383,021 $1.18 Million
Q2 2021

Aug 11, 2021

BUY
$2.57 - $4.85 $589,961 - $1.11 Million
229,557 Added 241.58%
324,581 $1.32 Million
Q1 2021

May 17, 2021

SELL
$1.9 - $2.82 $729,144 - $1.08 Million
-383,760 Reduced 80.15%
95,024 $235,000
Q4 2020

Feb 16, 2021

BUY
$1.15 - $2.4 $185,934 - $388,036
161,682 Added 50.99%
478,784 $1.02 Million
Q3 2020

Nov 16, 2020

SELL
$1.11 - $1.68 $89,136 - $134,909
-80,303 Reduced 20.21%
317,102 $384,000
Q2 2020

Aug 14, 2020

SELL
$1.69 - $4.2 $572,274 - $1.42 Million
-338,624 Reduced 46.01%
397,405 $684,000
Q1 2020

May 15, 2020

BUY
$1.26 - $3.38 $649,192 - $1.74 Million
515,232 Added 233.35%
736,029 $1.94 Million
Q4 2019

Feb 14, 2020

BUY
$0.86 - $1.44 $139,737 - $233,978
162,485 Added 278.65%
220,797 $296,000
Q3 2019

Nov 14, 2019

SELL
$1.21 - $1.59 $48,936 - $64,304
-40,443 Reduced 40.95%
58,312 $71,000
Q2 2019

Aug 16, 2019

BUY
$1.25 - $3.14 $14,520 - $36,474
11,616 Added 13.33%
98,755 $149,000
Q2 2019

Aug 14, 2019

SELL
$1.25 - $3.14 $51,905 - $130,385
-41,524 Reduced 32.27%
87,139 $132,000
Q1 2019

May 15, 2019

SELL
$2.79 - $4.09 $97,926 - $143,554
-35,099 Reduced 21.43%
128,663 $381,000
Q1 2018

May 15, 2018

BUY
$2.92 - $3.81 $412,698 - $538,486
141,335 Added 630.2%
163,762 $488,000
Q4 2017

Feb 14, 2018

SELL
$2.99 - $4.85 $158,766 - $257,530
-53,099 Reduced 70.31%
22,427 $69,000
Q3 2017

Nov 14, 2017

BUY
$3.01 - $5.41 $227,333 - $408,595
75,526
75,526 $355,000

Others Institutions Holding VSTM

About Verastem, Inc.


  • Ticker VSTM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 210,000,000
  • Market Cap $1.17B
  • Description
  • Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...
More about VSTM
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.